New drug tested for Tough-to-Treat blood cancer
NCT ID NCT06979076
Summary
This early-stage study is testing a new drug called MS-553 in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to previous treatments. The main goal is to check the drug's safety and side effects in about 12 patients. Researchers will monitor participants closely for any health changes or reactions to the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.